AU2012900572A0 - Compositions and methods for the treatment of cystic fibrosis - Google Patents

Compositions and methods for the treatment of cystic fibrosis

Info

Publication number
AU2012900572A0
AU2012900572A0 AU2012900572A AU2012900572A AU2012900572A0 AU 2012900572 A0 AU2012900572 A0 AU 2012900572A0 AU 2012900572 A AU2012900572 A AU 2012900572A AU 2012900572 A AU2012900572 A AU 2012900572A AU 2012900572 A0 AU2012900572 A0 AU 2012900572A0
Authority
AU
Australia
Prior art keywords
compositions
treatment
methods
cystic fibrosis
cystic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2012900572A
Inventor
Max Reynolds
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of AU2012900572A0 publication Critical patent/AU2012900572A0/en
Abandoned legal-status Critical Current

Links

AU2012900572A 2012-02-17 Compositions and methods for the treatment of cystic fibrosis Abandoned AU2012900572A0 (en)

Publications (1)

Publication Number Publication Date
AU2012900572A0 true AU2012900572A0 (en) 2012-03-01

Family

ID=

Similar Documents

Publication Publication Date Title
IL266582A (en) Compositions and methods for the treatment of hemoglobinopathies
EP2877159B8 (en) Efflux inhibitor compositions and methods of treatment using the same
EP2968285A4 (en) Compounds and methods for the treatment of cystic fibrosis
EP2736528A4 (en) Compositions and methods for the treatment of hiv
EP2847152A4 (en) Compositions and methods for the treatment of metabolic syndrome
IL227738B (en) Novel composition for the treatment of cystic fibrosis
EP3021839A4 (en) Methods and compositions for treatment of fibrosis
EP2830654B8 (en) Methods and compositions for treating inflammation
IL235358B (en) Tritoqualine for use in the treatment of cystic fibrosis
EP3046901A4 (en) Compositions for the treatment of hypertension and/or fibrosis
EP3046902A4 (en) Compositions for the treatment of hypertension and/or fibrosis
EP3068431A4 (en) Methods and compositions for the treatment of hcmv
ZA201408053B (en) Compositions and methods for the treatment of metabolic syndrome
AU2012900572A0 (en) Compositions and methods for the treatment of cystic fibrosis
AU2013901209A0 (en) Compositions and methods for the treatment of cystic fibrosis
GB201000499D0 (en) Treatment of cystic fibrosis
AU2012902982A0 (en) Compositions and methods for the treatment of tuberculosis
AU2012900569A0 (en) Compositions and methods for the treatment of herpes
AU2011901902A0 (en) Methods and compositions for the treatment of melanoma
AU2012903646A0 (en) Therapeutic methods and compositions
AU2012901350A0 (en) Therapeutic methods and compositions
AU2011902301A0 (en) Novel Formulation and Treatment Methods
GB201317932D0 (en) Novel compounds and pharmaceutical compositions thereof for the treatment of cystic fibrosis
GB201317935D0 (en) Novel compounds and pharmaceutical compositions thereof for the treatment of cystic fibrosis
GB201308137D0 (en) Novel compounds and pharmaceutical compositions thereof for the treatment of cystic fibrosis